Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Bulletin Du Cancer|October 15, 2019
[Cancers and environmental exposures: Between uncertainties and certainties]Nicole Falette, Béatrice Fervers, Julien CarretierBulletin Du Cancer|November 14, 2008
[Tumour genomics: an unstable landscape]Caroline Moyret-Lalle, Nicole Falette, Gaël Grelier, et al.Bulletin Du Cancer|September 24, 2004
BTG2, its family and its tutorCyril Duriez, Caroline Moyret-Lalle, Nicole Falette, et al.Biochemical Pharmacology|December 11, 2002
Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribineCarlos María Galmarini, Nathalie Voorzanger, Nicole Falette, et al.Oncogene|October 3, 2002
BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cellsFatiha el-Ghissassi, Sandrine Valsesia-Wittmann, Nicole Falette, et al.International Journal of Cancer|January 22, 2002
Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabineCarlos María Galmarini, Marilyn L Clarke, Nicole Falette, et al.Cancer Biology & Therapy|February 1, 2007
Weekly administration of paclitaxel induces long-term aneugenicity in nude miceCarlos M Galmarini, Benjamin P Bouchet, Nicole Falette, et al.Oncogene|December 5, 2003
Chfr inactivation is not associated to chromosomal instability in colon cancersJacques Bertholon, Qing Wang, Nicole Falette, et al.Gene|January 30, 2002
The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor geneCyril Duriez, Nicole Falette, Carole Audoynaud, et al.International Journal of Cancer|January 25, 2006
A p21/WAF1 mutation favors the appearance of drug resistance to paclitaxel in human noncancerous epithelial mammary cellsCarlos María Galmarini, Benjamin Pierre Bouchet, Carole Audoynaud, et al.Pageof 1